Clarivate Stock Jumps 26% on Day It Reported Third-Quarter Results and Updated Outlook

Clarivate Plc (NYSE: CLVT) shares rose 25.9% on Tuesday, closing at $2.09 against a previous close of $1.66, while the S&P 500 ETF (SPY) gained 0.30%. The stock traded on about 3.5 times its normal volume. The move came the same morning the company reported third-quarter 2026 results in an 8-K that furnished its earnings press release.

Adjusted earnings and recurring growth

Adjusted diluted EPS was $0.21 for the quarter, up from $0.18 a year earlier. Organic recurring revenue growth from subscriptions and re-occurring revenue was 1.3%, and organic ACV growth was 1.8%. Chief Executive Matti Shem Tov pointed to the return to positive ACV growth in the Intellectual Property segment.

Revenue and the divestiture

Revenue from continuing operations was $481.6 million, down from $530.3 million a year earlier, which the company attributed primarily to inorganic disposals. The company completed the sale of its Life Sciences & Healthcare segment on Oct. 6, 2026, for net cash proceeds of $488.4 million, and reported that segment as discontinued operations. Net loss including that segment was $80.8 million, or $0.13 per diluted share, driven by a $62.2 million non-cash goodwill impairment.

Outlook and debt

The company updated its full-year 2026 outlook, with adjusted diluted EPS of $0.73 to $0.77 and free cash flow of $320 million to $340 million. Its fourth-quarter outlook calls for adjusted diluted EPS of $0.14 to $0.18. Total debt stood at $4,176.1 million at September 30, 2026, down $293.8 million from a year earlier.